Cargando…

Multipeptide stimulated PBMCs generate T(EM)/T(CM) for adoptive cell therapy in multiple myeloma

Multiple Myeloma (MM) patients suffer disease relapse due to the development of therapeutic resistance. Increasing evidence suggests that immunotherapeutic strategies can provide durable responses. Here we evaluate the possibility of adoptive cell transfer (ACT) by generating ex vivo T cells from pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vardam-Kaur, Trupti, Pathangey, Latha B., McCormick, Daniel J., Bergsagel, P. Leif, Cohen, Peter A., Gendler, Sandra J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487724/ https://www.ncbi.nlm.nih.gov/pubmed/34611479 http://dx.doi.org/10.18632/oncotarget.28067

Ejemplares similares

Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniae
por: Maricic, Natalie, et al.
Publicado: (2016)

Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017)

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells
por: Basu, Gargi D, et al.
Publicado: (2005)

Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes
por: Pathangey, Latha B., et al.
Publicado: (2016)

Extracellular vesicle proteomic analysis leads to the discovery of HDGF as a new factor in multiple myeloma biology
por: Hoelzinger, Dominique B., et al.
Publicado: (2022)

Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens
por: Pathangey, Latha B., et al.
Publicado: (2016)

Revisiting checkpoint inhibitors for myeloma: maintenance after stem cell transplant
por: Meermeier, Erin W., et al.
Publicado: (2023)

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist
por: Meneveau, Max O, et al.
Publicado: (2021)

Comparing the EMS adopter and EMS non-adopter organizations in achieving sustainable business goals
por: Wang, Yizhou, et al.
Publicado: (2022)

Review of Multiple Myeloma Genetics including Effects on Prognosis, Response to Treatment, and Diagnostic Workup
por: Wiedmeier-Nutor, Julia Erin, et al.
Publicado: (2022)

UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression
por: Hussain, Sajjad, et al.
Publicado: (2015)

Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma
por: Perales, Miguel-Angel, et al.
Publicado: (2008)

Prevention of “Humanized” Diabetogenic CD8 T-Cell Responses in HLA-Transgenic NOD Mice by a Multipeptide Coupled-Cell Approach
por: Niens, Marijke, et al.
Publicado: (2011)

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients
por: Melssen, Marit M., et al.
Publicado: (2019)

Tolerogenic vaccine composited with islet-derived multipeptides and cyclosporin A induces pTreg and prevents Type 1 diabetes in murine model
por: Zhou, Xian, et al.
Publicado: (2019)

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine
por: Mauldin, Ileana S, et al.
Publicado: (2015)

Frequent occurrence of large duplications at reciprocal genomic rearrangement breakpoints in multiple myeloma and other tumors
por: Demchenko, Yulia, et al.
Publicado: (2016)

Adoptive Immunotherapy and High-Risk Myeloma
por: Duane, Catherine, et al.
Publicado: (2023)

Single-cell immune checkpoint landscape of PBMCs stimulated with Candida albicans
por: Deng, Weiwei, et al.
Publicado: (2021)

Systolic dysfunction associated with carfilzomib use in patients with multiple myeloma
por: Jain, Tania, et al.
Publicado: (2017)

Walter Michael Kuehl, MD - October 25, 1939 - April 30, 2023
por: Bergsagel, Leif
Publicado: (2023)

GABA and Combined GABA with GAD65-Alum Treatment Alters Th1 Cytokine Responses of PBMCs from Children with Recent-Onset Type 1 Diabetes
por: Heath, Katie E., et al.
Publicado: (2023)

Evaluation of quantitative biomarkers of aging in human PBMCs
por: Owen, Brady M., et al.
Publicado: (2023)

Responses of Transgenic Melatonin-Enriched Goats on LPS Stimulation and the Proteogenomic Profiles of Their PBMCs
por: Yang, Minghui, et al.
Publicado: (2018)

Analysis of microRNA expression profiles in porcine PBMCs after LPS stimulation
por: Zhang, Jing, et al.
Publicado: (2020)

Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB
por: Demchenko, Yulia N., et al.
Publicado: (2014)

Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99
por: Kim, Young-Hee, et al.
Publicado: (2016)

Cell-to-Cell Interactions and Signals Involved in the Reconstitution of Peripheral CD8(+) T(CM) and T(EM) Cell Pools
por: Zaragoza, Bruno, et al.
Publicado: (2011)

Changes in the number of circulating T(CM) and T(EM) subsets in renal transplantation: relationship with acute rejection and induction therapy
por: Segundo, David S, et al.
Publicado: (2011)

Identification of Discriminating Metabolic Pathways and Metabolites in Human PBMCs Stimulated by Various Pathogenic Agents
por: Zhang, Xiang, et al.
Publicado: (2018)

Regulation of Inflammatory Gene Expression in PBMCs by Immunostimulatory Botanicals
por: Denzler, Karen L., et al.
Publicado: (2010)

Genotypic characterization of HIV variants from PBMCs and spermatozoa
por: Sutar, Jyoti P, et al.
Publicado: (2014)

Urocortin Neuropeptide Levels Are Impaired in the PBMCs of Overweight Children
por: Kavalakatt, Sina, et al.
Publicado: (2022)

Plasma Purification Treatment Relieves the Damage of Hyperlipidemia to PBMCs
por: Zhang, Xiao Meng, et al.
Publicado: (2021)

Cryo-EM structure of mouse TRPML2 in lipid nanodiscs
por: Song, Xiaojing, et al.
Publicado: (2021)

Human PBMCs Form Lipid Droplets in Response to Spike Proteins
por: Sivaraman, Kokilavani, et al.
Publicado: (2023)

Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages
por: Incio, Joao, et al.
Publicado: (2015)

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice
por: Lakshminarayanan, Vani, et al.
Publicado: (2016)

MicroRNA expression profiling in PBMCs of Indian water Buffalo (Bubalus bubalis) infected with Brucella and Johne’s disease
por: Singh, Jasdeep, et al.
Publicado: (2020)

Effect of LPS and LTA stimulation on the expression of TLR-pathway genes in PBMCs of Akkaraman lambs in vivo
por: Aksel, Esma Gamze, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_teoitvkpb4ehjliog37uk7e0td